Citius Oncology (CTOR) Current Assets (2021 - 2026)

Citius Oncology's Current Assets history runs 6 years deep, the most recent figure standing at $29.4 million for Q1 2026.

• In Q1 2026, Current Assets rose 63.11% year-over-year to $29.4 million; the TTM figure through Mar 2026 stood at $29.4 million (up 63.11% YoY), while the FY2025 annual figure was $27.5 million, up 151.1% from the prior year.
• Current Assets was $29.4 million for Q1 2026 at Citius Oncology, down from $37.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $37.1 million in Q4 2025 to a low of $40988.0 in Q2 2024.
• Historically, Current Assets has averaged $12.0 million across 5 years, with a median of $9.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Assets plunged 91.13% in 2024, then jumped 44569.36% in 2025.
• A 5-year view of Current Assets shows it stood at $377344.0 in 2022, then slumped by 84.58% to $58200.0 in 2023, then soared by 29249.62% to $17.1 million in 2024, then surged by 117.47% to $37.1 million in 2025, then declined by 20.79% to $29.4 million in 2026.
• The last three Current Assets figures came in at $29.4 million (Q1 2026), $37.1 million (Q4 2025), and $27.5 million (Q3 2025), per Business Quant data.